Search for: "PFIZER" Results 4001 - 4020 of 4,626
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jan 2008, 9:00 am
., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz that use of Markush group language in the specification does not necessarily limit construction of claim terms: (Chicago IP Litigation),Coreg / Dilatrend / Eucardic (Carvedilol) - Teva Pharmaceutical Industries… [read post]
2 Oct 2008, 12:36 pm
We've discussed the learned intermediary rule on this blog many times before - such as here, here, and here. [read post]
27 Jul 2012, 12:40 pm by Bexis
Pfizer, Inc., 990 A.2d 17, 21 n.1 (Pa.Super. 2010) (rejecting fraud claim concerning promotion “for off-label uses for which the effectiveness had not been scientifically demonstrated”). [read post]
30 Jan 2015, 8:19 pm by Schachtman
The MDL Court then proceeded to expand upon its earlier ruling, and to explain how Matrixx was largely irrelevant to the Rule 702 context of Pfizer’s challenge to Dr. [read post]
30 Aug 2013, 7:35 am by vqab
Another interesting collaboration example is Pfizer Legal Alliance, a collaboration program for Pfizer’s outside couns [read post]
5 Jan 2011, 1:17 am by Kevin LaCroix
  One final note about the Pfizer derivative lawsuit settlement concerns the unusual funding mechanism the settlement implemented. [read post]
6 Jan 2021, 5:01 am by Abby Lemert, Eleanor Runde
The Sinopharm vaccine relies on different and more traditional medical techniques than the Pfizer or Moderna vaccines approved by the United States, and producing Sinopharm’s vaccine takes longer. [read post]
26 Apr 2022, 7:48 am by Paul Stephan
Pundits have reveled in the prospect of using the Russian central bank funds currently frozen by the U.S. [read post]
31 Dec 2020, 11:41 pm by Florian Mueller
Pfizer/BioNTech offered the EU 500 million doses, and Moderna (which uses the same type of technique, mRNA) another 300 million. [read post]
20 Jan 2022, 6:01 am by Tanner Larkin
All 21 of the defendants belong to the corporate families AstraZeneca, GE Healthcare, Johnson & Johnson, Pfizer or Roche. [read post]
2 Mar 2012, 6:52 am by Bexis
Pfizer (femoral stem) Deposition1998-06-30 Suerth v. [read post]
9 Aug 2012, 5:00 am by Bexis
Pfizer (femoral stem) Deposition1998-06-30 Suerth v. [read post]
9 Apr 2021, 8:03 am by Lisa Larrimore Ouellette
The mRNA platform used by the Moderna and Pfizer-BioNTech vaccines is exciting in part because the vaccines can be produced more quickly than with older technologies, but a key bottleneck has been the small number of facilities that can make lipid nanoparticles for encapsulating the mRNA. [read post]
26 Jul 2019, 11:18 am
In particular, the Dutch District Court of The Hague’s decision that tromethamine cannot be considered equivalent to disodium in contrast to many other national courts.GuestKat Rose Hughes summarised the appeal in J 05/18 and in particular the finding that an isolated error in a well-functioning system is not equivalent to all due care.This was followed up with a further post from Rose on the refusal of Mr Justice Birss to grant an arrow declaration in… [read post]
1 Aug 2019, 2:14 am
Earlier this year, the UK courts considered the validity of Genentech's patent for Taltz, an anti-IL-17 monoclonal antibody (IPKat post here), and last month, the courts considered Pfizer's request for an Arrow declaration relating to Roche's monoclonal antibody drug Avastin (bevacizumab) (IPKat post here).The latest UK High Court patent decision (Takeda v Roche [2019] EWHC 1911) relates to another pair of pharmaceutical company giants (Takeda and Roche), and… [read post]
6 Feb 2015, 6:31 am
 The first was the Minutes of  Meeting of the North of Tyne Area Prescribing Committee (“APC”) on 13 January 2015 which extraordinarily concluded as follows:Pfizer have contacted CCGs and community pharmacies to highlight that they believe the supply of generic pregabalin for use in the treatment of pain, whilst the pain patent remains in force in the UK, would infringe Pfizer’s patent rights. [read post]